We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Dual-Functional Fluorescent Probe for DNA Hybridization and Melting Point Analysis

By LabMedica International staff writers
Posted on 20 Aug 2013
Print article
Image: Eprobe, a highly efficient and reliable fluorescent probe for PCR DNA amplification techniques and DNA analysis in hybridization experiments, has been developed by researchers from the Japanese firms RIKEN and K.K. DNAFORM. This technology will enable the development of new, advanced assays for DNA-based genetic testing and help to bring the benefits of genome-wide sequencing studies to patients in the clinic (Photo courtesy of RIKEN).
Image: Eprobe, a highly efficient and reliable fluorescent probe for PCR DNA amplification techniques and DNA analysis in hybridization experiments, has been developed by researchers from the Japanese firms RIKEN and K.K. DNAFORM. This technology will enable the development of new, advanced assays for DNA-based genetic testing and help to bring the benefits of genome-wide sequencing studies to patients in the clinic (Photo courtesy of RIKEN).
Japanese researchers have described a new approach for combining real-time PCR amplification and melting curve analysis in a single-tube reaction, which provides a powerful means for new mutation detection assays.

This technology, which was jointly developed by the RIKEN Center for Life Science Technologies (Saitama, Japan) and K.K. DNAFORM (Yokohama City, Japan) will enable the development of new, advanced assays for DNA-based genetic testing and should help to bring the benefits of genome-wide sequencing studies to patients in the clinic.

The new methodology is based on RIKEN's Eprobe, a highly efficient and reliable fluorescent probe. Eprobes contain two dye moieties attached to the same nucleotide, and their fluorescent signal is strongly suppressed as single-stranded oligonucleotides by an excitonic interaction between the dyes. Upon hybridization to a complementary DNA strand, the dyes are separated and intercalate into the double-strand leading to strong fluorescence signals. Furthermore, intercalation of dyes further stabilizes the DNA/DNA hybrid and increases the melting temperature compared to standard DNA oligonucleotides. Thus, Eprobes allow for specific real-time monitoring by amplification while enabling study of reaction products by melting curve analysis.

In a recent study, the investigators used Eprobes for the detection of genetic variations in a human EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) tumor. They demonstrated that Eprobes provided decisive advantages over commonly used hybridization probes because of their unique background signal reduction, enhanced DNA-binding affinity, and very low false positives rate.

"We are very excited about the potential of the new Eprobes,” said Dr. Matthias Harbers, a visiting scientist at the RIKEN Center for Life Science. "In the reactions, Eprobes acted like sequence-specific fluorescent dyes, which gives them great potential for use as hybridization probes not only in PCR and melting curve analysis but also in other important applications like, for instance, in fluorescent in situ hybridization or FISH."

The Eprobe study was published in the August 7, 2013, online edition of the journal PLOS ONE.

Related Links:

RIKEN Center for Life Science Technologies
K.K. DNAFORM


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.